Free tool
Oncology stocks
We cover 1 company grouped under the Oncology theme. The median market value in the group is $10.66B. Across the group, the median move over the past trading day is +4.95%. Price change over the past year runs from −49.1% to −49.1% across the middle 80 percent of the group, with a median of −49.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 319 matches these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | $13.36 | +1.95% | −23.74% | −49.14% | Oct 19, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.